Source comparison
Research Design Considerations for Selank–Semax Comparisons
Several experimental design variables are critical for interpretable Selank–Semax comparative research. First, route and timing of administration: both peptides are active via nasal delivery in rodents (documented intranasal bioavailability at 100 µg/kg), and
This comparison does not assign a generated winner or score.
- Several experimental design variables are critical for interpretable Selank–Semax comparative research. First, route and timing of administration: both peptides are active via nasal delivery in rodents (documented intranasal bioavailability at 100 µg/kg), and i.n. administration is the standard research route. Intraperitoneal administration produces different kinetic profiles. Administration timing relative to behavioural testing is critical: Semax’s BDNF effect peaks at 4–12 hours post-administration (mRNA at 4h, protein at 8–12h), meaning Semax administered 30 minutes pre-test engages acute MC4R/cAMP effects but not peak BDNF protein effects. Chronic administration (14–28 days) is required to study Semax’s full BDNF-LTP neuroplasticity effects, whereas Selank’s GABA-A and 5-HT2C effects are acute (30–60 minutes post-administration).
- Second, strain selection matters: C57BL/6 mice are low-anxiety and show floor effects in EPM (open-arm time ~18–22% baseline vs the 8–12% seen in high-anxiety BALB/c), potentially masking Selank’s anxiolytic advantage in EPM. BALB/c mice, which are high-anxiety, show larger Selank EPM effects (open-arm time: BALB/c vehicle 10–12%; BALB/c Selank 28–34%) than C57BL/6 (18–22% → 38–44%). Researchers studying Selank’s anxiolytic-cognitive facilitation should consider BALB/c or Sprague–Dawley high-anxiety backgrounds where the GABA-A mechanism operates across a wider dynamic range.
- Third, the cognitive task chosen determines which mechanism predominates. Anxiolytic-sensitive tasks (EPM, open-field novelty, social interaction under stress) favour Selank. Hippocampal neuroplasticity tasks (MWM, novel object location, contextual fear extinction, LTP electrophysiology) favour Semax. CUS model research where both HPA normalisation and BDNF restoration are relevant may show the clearest Selank+Semax additive benefit at sub-effective individual doses.